Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 8/20 | 0.70 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.66 |
| ▸ | ACE | P12821 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | MPO | P05164 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | ERAP1 | Q9NZ08 | 3/20 | 0.60 |
| ▸ | IL1RN | P18510 | 2/20 | 0.60 |
| ▸ | MMP2 | P08253 | 2/20 | 0.59 |
| ▸ | MMP9 | P14780 | 1/20 | 0.59 |
| ▸ | MMP8 | P22894 | 1/20 | 0.59 |
| ▸ | MMP1 | P03956 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29794195 | 1.00 | ECE1 (0.70) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL7622335 | 1.00 | ECE1 (0.70) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL29352768 | 1.00 | ECE1 (0.70) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL8776396 | 1.00 | ECE1 (0.70) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL30991071 | 1.00 | ECE1 (0.70) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL29538468 | 0.98 | ERAP2 (0.69) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL30051905 | 0.97 | ECE1 (0.69) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL30051545 | 0.96 | ECE1 (0.65) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL29987530 | 0.95 | ECE1 (0.64) | ECE1ERAP2ACEKDM4EMEN1 | |
| SCHEMBL30051546 | 0.95 | ERAP2 (0.73) | ECE1ERAP2ACEERAP1IL1RN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060768-A | African swine fever oral vaccine saccharomyces cerevisiae engineering bacteria, and construction method and application thereof | 天津科技大学 | 2026-05-19 | — | — | CN | claimed |
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250115654-A1 | PHARMACEUTICAL COMPOSITION OF GLP-1 RECEPTOR AND GIP RECEPTOR DUAL AGONIST, AND USE THEREOF | Fujian Shengdi Pharmaceutical Co., Ltd. (CN) | 2025-04-10 | — | — | US | claimed |
| CN-118561957-B | Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide VKGVF, FGGAL, WLDAN and application thereof | 中国水产科学研究院黄海水产研究所 | 2025-03-04 | — | — | CN | claimed |
| CN-119350437-A | Xanthine oxidase inhibitory peptide of tuna of source Yu Qinggan and application thereof | 中国海洋大学三亚海洋研究院 | 2025-01-24 | — | — | CN | claimed |
| WO-2024235070-A1 | PEPTIDE COMPOUND, COMPOSITION AND USE THEREOF | 杭州禾泰健宇生物科技有限公司 | 2024-11-21 | — | — | WO | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-118754965-A | GLP-1 and GIP receptor dual agonist compounds and uses thereof | 北京拓界生物医药科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118561957-A | Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide VKGVF, FGGAL, WLDAN and application thereof | 中国水产科学研究院黄海水产研究所 | 2024-08-30 | — | — | CN | claimed |
| CN-113912673-B | Sesame-derived low-bitter ACE (angiotensin converting enzyme) inhibitory peptide as well as preparation method and application thereof | 河南省农业科学院 | 2024-02-09 | — | — | CN | claimed |
| EP-4291647-A1 | SUBTILISIN VARIANTS AND THEIR USE | Fresenius Kabi iPSUM S.r.l. (IT) | 2023-12-20 | — | — | EP | claimed |
| EP-3766545-B1 | ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION | CUTANEON SKIN & HAIR INNOVATIONS GMBH (DE) | 2023-08-16 | — | — | EP | claimed |
| US-20230190879-A1 | DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2023-06-22 | — | — | US | claimed |
| CN-115397836-A | Novel antibacterial peptide and application thereof | 安尼根有限公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2022171667-A1 | SUBTILISIN VARIANTS AND THEIR USE | Fresenius Kabi Ipsum S.R.L. (IT) | 2022-08-18 | — | — | WO | claimed |
| US-20220168206-A1 | ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2022-06-02 | — | — | US | claimed |
| US-20220168396-A1 | MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2022-06-02 | — | — | US | claimed |
| EP-0347890-B1 | AMINO ACID NUTRIENT COMPOSITIONS | Roussel Morishita Co., Ltd. (JP) | 1993-03-17 | — | — | EP | claimed |
| US-5036052-A | Containing a dipeptide of tryptophan and alanine or lecine and no stabilizer; discoloration inhibition | MORISHITA PHARMACEUTICAL CO., LTD. (JP) | 1991-07-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190879-A1 | DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF | GLP1R, GIPR, GPR119 | ECE1 4035/4885ERAP2 683/4885ACE 3908/4885 |
| US-20260060913-A1 | BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS | TYR, CUTA, ARGLU1 | ECE1 4095/4885ERAP2 1999/4885ACE 3524/4885 |
| US-20220168396-A1 | MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF | GLP1R, GIPR, GCGR | ECE1 3421/4885ERAP2 1421/4885ACE 2658/4885 |
| US-20250115654-A1 | PHARMACEUTICAL COMPOSITION OF GLP-1 RECEPTOR AND GIP RECEPTOR DUAL AGONIST, AND USE THEREOF | GLP1R, GIPR, GCGR | ECE1 2794/4885ERAP2 1636/4885ACE 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.